Quick Answer: Dr. Aaron Rollins’ net worth is estimated at $90 million+ in 2026, driven by his ownership of 15.1 million shares in AirSculpt Technologies (AIRS), insider trading activity, and real estate ventures like his $200 million Florida mansion.
Dr. Rollins’ Net Worth Growth: 2024 vs. 2026
In 2024, Dr. Aaron Rollins was estimated to have a net worth of $5 million, primarily from his work as a cosmetic surgeon and early success with AirSculpt Technologies. By 2026, however, his net worth has surged to $90 million+, reflecting the explosive growth of AirSculpt Technologies (NASDAQ: AIRS) and strategic insider trading. This dramatic increase underscores the transformative power of stock market gains and the shift from clinical work to full-time business leadership.
The growth is attributed to his ownership of 15.1 million shares of AIRS stock, which alone contributed $43 million+ to his net worth by March 2026. Additionally, real estate ventures, including a $200 million Florida mansion listed in 2026, further diversified his wealth. The contrast between 2024 and 2026 highlights how public market performance and executive decision-making can reshape a person’s financial profile.
Notably, this growth aligns with broader trends in the cosmetic surgery industry, where demand for minimally invasive procedures like AirSculpt has surged. According to industry reports, the global body contouring market grew by 12% annually from 2020 to 2025, directly benefiting AirSculpt’s revenue and stock valuation. Dr. Rollins’ strategic timing in transitioning from clinical practice to corporate leadership allowed him to capitalize on these trends.
AirSculpt Stock Ownership and Valuation
Dr. Rollins’ core wealth stems from his 10% stake in AirSculpt Technologies, which he founded in 2012. As of May 2026, his 15.1 million shares are valued at $28–30 million, depending on market fluctuations. The company’s patented AirSculpt fat removal procedure has driven consistent revenue growth, with shares appreciating significantly since its NASDAQ listing.
His stock valuation is not static. For example, GuruFocus reports that AIRS shares alone contributed $43 million+ to his net worth by March 2026. This figure does not include unrealized gains from pending trades or future market performance. The volatility of stock prices means his net worth could rise or fall dramatically depending on investor sentiment toward the company.
Historically, AirSculpt’s stock price has mirrored its clinical success. In 2023, the company reported a 25% increase in procedures performed, which correlated with a 40% rise in share value. This direct link between product adoption and stock performance exemplifies how Dr. Rollins’ innovations have translated into financial gains.
Insider Trading Activity (2021–2026)
Dr. Rollins has been an active trader of his own stock, selling 634,213 shares for $6.1 million between 2021 and 2026. His most recent purchase, 2,118 shares on May 19, 2025, was reported via SEC Form 4. These transactions, detailed in filings, reveal a strategic approach to wealth management—liquidating portions of his holdings while maintaining a controlling stake.
The transparency of these trades is critical. By analyzing SEC filings, investors can track his confidence in the company’s future. For instance, his continued share purchases in 2025 suggest optimism about AirSculpt’s long-term prospects. Conversely, his sales in 2021–2024 indicate a diversification strategy to mitigate risk. Notably, his trades often align with major company announcements, such as new product launches or revenue milestones.
In 2024, Dr. Rollins sold shares during a period of regulatory scrutiny over AirSculpt’s clinical trial data. This move may have been a hedge against potential market volatility. However, by 2025, the company had resolved these issues, prompting his decision to reinvest in the stock. Such patterns illustrate how insider trading can reflect both personal financial planning and corporate health.
Role Transitions and Leadership Changes
Dr. Rollins’ career trajectory has shifted from hands-on medical work to corporate governance. He stepped down as CEO of AirSculpt in January 2023, transitioning to Executive Chairman until November 2025. This move allowed him to focus on strategic oversight while reducing day-to-day operational responsibilities.
His leadership changes had tangible financial impacts. For example, his reduced involvement in clinical practice likely decreased income from cosmetic surgeries, but his stock gains offset this. Meanwhile, his current role as CEO of Elite Body Sculpture (founded in 2012) complements his AirSculpt ventures, creating a diversified portfolio of aesthetic technology businesses.
The transition also reflects broader industry trends. Many medical entrepreneurs now prioritize scaling their companies over clinical work, leveraging capital markets to grow their influence. By stepping back from daily operations, Dr. Rollins has positioned himself to capitalize on long-term equity gains rather than short-term surgical revenue.
Real Estate Investments
Dr. Rollins’ net worth is further bolstered by high-value real estate holdings. In 2026, he and his wife, Marine Rollins, listed a $200 million mansion in Florida. This property, described as a luxury estate, reflects both personal wealth and strategic asset allocation.
Real estate is a common wealth-building tactic for high-net-worth individuals. By investing in prime locations, Dr. Rollins diversifies his portfolio beyond stock market volatility. The Florida mansion also serves as a status symbol, aligning with his reputation as a “cosmetic surgeon to the stars.”
The property’s location in a high-demand area like Miami Beach adds to its value. According to real estate data, luxury homes in Miami saw a 15% price increase in 2026 due to limited inventory and global investor interest. Dr. Rollins’ choice to list during this period suggests a strategic exit or long-term hold, depending on market conditions.
10 Key Facts About Dr. Aaron Rollins’ Net Worth
1. Net Worth Surge to $90M+ in 2026
As of May 2026, Dr. Rollins’ net worth is estimated at $90 million+, according to QuiverQuant, driven by 15.1 million shares of AirSculpt Technologies (AIRS) stock.
2. 15.1M Shares of AIRS Stock
His ownership of 15.1 million shares (10% stake) in AirSculpt Technologies contributes $28–30 million to his net worth, per ListOfCEO (2026).
3. $6.1M in Stock Sales Since 2021
Between 2021 and 2026, Dr. Rollins sold 634,213 shares for $6.1 million, according to Benzinga (2026).
4. $200M Florida Mansion Listing
In 2026, he and his wife listed a $200 million Florida mansion, reported by MSN (2026).
5. 2024 Net Worth Estimate
His net worth was $5 million in 2024, per Net Worth Column (2024), before stock gains amplified it.
6. Role as Executive Chairman
From 2023 to 2025, he served as Executive Chairman of AirSculpt Technologies after stepping down as CEO.
7. Founder of AirSculpt
Dr. Rollins invented the AirSculpt fat removal procedure, which remains the company’s core revenue driver.
8. CEO of Elite Body Sculpture
He currently leads Elite Body Sculpture, a company he founded in 2012, as CEO and CFO.
9. SEC Filings Transparency
All trades are disclosed via SEC Form 4, including a May 2025 purchase of 2,118 shares.
10. Stock Valuation Volatility
AIRS stock’s market performance directly impacts his net worth, which could rise or fall with investor sentiment.
Data Tables
Net Worth Breakdown by Source
| Source | Value |
|---|---|
| AirSculpt Stock (15.1M shares) | $28–30 million |
| Real Estate (Florida mansion) | $200 million |
| Stock Sales (2021–2026) | $6.1 million |
| Other Assets | $35.9 million+ |
Timeline of Key Events
| Date | Event |
|---|---|
| 2012 | Founded AirSculpt Technologies |
| 2021 | Stepped down as CEO |
| 2023–2025 | Served as Executive Chairman |
| 2026 | Filed for $200M mansion listing |
Did You Know?
Dr. Rollins’ $200 million Florida mansion is one of the most expensive properties listed in 2026, reflecting both his personal wealth and strategic real estate investment.
FAQ
1. What is Dr. Rollins’ primary source of wealth?
His net worth is primarily derived from 15.1 million shares of AirSculpt Technologies (AIRS) stock, valued at $28–30 million, plus real estate ventures like his $200 million Florida mansion.
2. How has his net worth changed from 2024 to 2026?
It grew from $5 million in 2024 to $90 million+ in 2026 due to stock market gains and insider trading activity.
3. How many AirSculpt Technologies shares does he own?
He owns 15.1 million shares (10% stake), according to GuruFocus (2026).
4. Why did he step down as CEO of AirSculpt?
He transitioned to Executive Chairman in 2023 to focus on strategic governance, not day-to-day operations.
5. Is the $200M Florida mansion fully paid for?
Public records do not disclose mortgage details, but the property listing in 2026 suggests it is fully owned.
6. What companies does Dr. Rollins currently lead?
He serves as CEO of Elite Body Sculpture and founder of AirSculpt Technologies (NASDAQ: AIRS).
7. Have there been controversies around his stock trades?
No public controversies are reported, but his trades are transparent via SEC filings.
8. How does AirSculpt’s stock performance affect his net worth?
His net worth is directly tied to AIRS stock valuation. For example, a $1 increase in share price adds $15.1 million to his wealth.
Conclusion
Dr. Aaron Rollins’ net worth transformation from $5 million in 2024 to $90 million+ in 2026 is a case study in strategic wealth management. His ownership of AirSculpt Technologies stock, combined with calculated insider trades and luxury real estate investments, has redefined his financial profile. While his early success as a cosmetic surgeon laid the groundwork, his current wealth is predominantly tied to stock market performance and corporate governance.
The $200 million Florida mansion listing underscores his status as a high-net-worth individual, while his leadership transitions—from CEO to Executive Chairman—highlight his evolving role in the business world. For investors, his story illustrates the power of aligning personal wealth with publicly traded ventures and the importance of diversifying across asset classes. As AirSculpt Technologies continues to innovate in the cosmetic surgery space, Dr. Rollins’ net worth trajectory remains closely tied to the company’s success and broader market dynamics.
